2024
|
Invention
|
Compositions and methods for multivalent immune responses.
The disclosure provides nanoparticle ... |
|
Invention
|
Compositions and methods for enhanced antigen binding proteins.
The disclosure provides nanopart... |
|
Invention
|
Nucleic acid sensor agonist compositions and uses thereof.
The disclosure provides nanoparticle ... |
|
Invention
|
Sars-cov-2 rna vaccine compositions and methods of use.
The disclosure provides compositions, me... |
|
Invention
|
Compositions and methods for enhanced protein production.
The disclosure provides nanoparticle a... |
|
Invention
|
Rna vaccines against infectious diseases.
The disclosure provides compositions, methods of treat... |
|
Invention
|
Dried nanoparticle compositions.
Provided herein are dried compositions and methods for preparin... |
|
Invention
|
Cancer therapy compositions and uses thereof.
The disclosure provides compositions, methods of t... |
|
Invention
|
Nanoparticle complexes for enhanced safety. The disclosure provides compositions, methods of trea... |
2023
|
Invention
|
Compositions and methods for delivery of rna. The disclosure provides nanoemulsion compositions a... |
|
Invention
|
Immune system modulators and uses thereof. The disclosure provides compositions, methods of treat... |
|
Invention
|
Compositions and methods for multivalent immune responses. The disclosure provides nanoparticle a... |
2022
|
Invention
|
Compositions and methods for enhanced protein production. The disclosure provides nanoparticle an... |
|
Invention
|
Nucleic acid sensor agonist compositions and uses thereof. The disclosure provides nanoparticle c... |
|
Invention
|
Compositions and methods for enhanced antigen binding proteins. The disclosure provides nanoparti... |
|
Invention
|
Cancer therapy compositions and uses thereof. The disclosure provides compositions, methods of tr... |
|
P/S
|
Nanoparticle formulations as components of RNA-based vaccines, namely, RNA drug delivery agents c... |
|
P/S
|
Nanoparticle formulations as components of nucleic acid-based vaccines, medicines, and pharmaceut... |
|
Invention
|
Nucleic acid-small diameter and liquid core nanoparticle complexed compositions. The disclosure p... |
|
Invention
|
Detection of desmoglein-2 in cancers of epithelial origin.
The disclosure provides methods of di... |
|
Invention
|
Compositions and methods for delivery of rna-lipid nanoparticle complexes encoding for viral rna ... |
|
Invention
|
Rna vaccines against infectious diseases. The disclosure provides compositions, methods of treatm... |
|
Invention
|
Dried nanoparticle compositions. Provided herein are dried compositions and methods for preparing... |
|
Invention
|
Sars-cov-2 rna vaccine compositions and methods of use. The disclosure provides compositions, met... |
2021
|
Invention
|
Compositions and methods for delivery of nucleic acid-lipid nanoparticle complexes encoding for v... |
|
Invention
|
Compositions and methods for delivery of rna.
The disclosure provides nanoemulsion compositions ... |
|
Invention
|
Rna-lipid nanoparticle complexes of viral rna polymerase region and sars-cov-2 spike protein regi... |
|
Invention
|
Nanoemulsion compositions and methods for delivery of nra. A composition comprising RNA molecules... |
2020
|
Invention
|
Detection of desmoglein-2 in cancers of epithelial origin. The disclosure provides methods of dia... |
2019
|
Invention
|
Conjugatable desmoglein 2 (dsg2) binding proteins and uses therefor.
The disclosure provides pol... |